According to PharmaSGP's latest financial reports the company has $42.18 Million USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $45.06 M | 24% |
2022-12-31 | $36.34 M | 54.11% |
2021-12-31 | $23.58 M | 139.64% |
2020-12-31 | $9.84 M | -90.07% |
2019-12-31 | $99.11 M |